ADX Study (protocol number: ADX-038-202)
A Study of Subcutaneous Injection of ADX-038 in Participants With GA Secondary to AMD.
This is a Phase 2 study designed to assess the safety and efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD.
Principle Investigator: A/Prof Fred Chen
ClinicalTrials.gov Identifier: NCT06990269
You may visit the ClinicalTrials.Gov website at Home | ClinicalTrials.gov for more information regarding this study.
To enquire further about this study, please contact the Clinical Trials Office on (08) 9381 0750, or email lionsvisiontrials@lei.org.au.
